The Greenrose Holding Company Inc.
$0.00-50.00%($-0.00)
TickerSpark Score
51/100
93
Valuation
85
Profitability
10
Growth
36
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GNRS research report →
52-Week Range0% of range
Low $0.00
Current $0.00
High $0.28
Companywww.greenroseholdings.com
Greenrose Holding Company Inc. , through its subsidiaries, engages in the production and sale of cannabis products. It engages in cultivating, processing, and packaging medical cannabis and derivative products.
- CEO
- Nicole Conboy
- IPO
- 2020
- Employees
- 91
- HQ
- Amityville, NY, US
Price Chart
-99.98% · this period
Valuation
- Market Cap
- $1.77K
- P/E
- 0.00
- P/S
- 0.00
- P/B
- 0.00
- EV/EBITDA
- 4.51
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 59.05%
- Op Margin
- 38.74%
- Net Margin
- 70.59%
- ROE
- 14.83%
- ROIC
- 4.30%
Growth & Income
- Revenue
- $25.39M · -10.50%
- Net Income
- $17.93M · 2408.59%
- EPS
- $1.12 · -67.63%
- Op Income
- $9.84M
- FCF YoY
- 223.11%
Performance & Tape
- 52W High
- $0.28
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- -170.34
- Avg Volume
- 1.68K
Get TickerSpark's AI analysis on GNRS
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 8, 22 | Wang Bernard | other | 131,887 |
| Aug 5, 22 | ROSE BENJAMIN | other | 0 |
| Jun 7, 22 | Megale Thomas J | other | 0 |
| Dec 22, 21 | Stegner Jeffrey | other | 0 |
| Feb 18, 22 | Megale Thomas J | other | 22,480 |
| Feb 18, 22 | Cummings Steven Francis | other | 29,388 |
| Feb 18, 22 | Falcon John | buy | 51,220 |
| Feb 18, 22 | Torrance John III | other | 27,709 |
| Dec 22, 21 | Cohen Scott Jeffrey | other | 10,000 |
| Feb 3, 22 | Greenrose Associates LLC | buy | 685,289 |
Our GNRS Coverage
We haven't published any research on GNRS yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GNRS Report →Similar Companies
INTP+0.00%
Integrated Pharmaceuticals, Inc.
$0.00
RXEI+0.00%
RxElite, Inc.
$0.00
MLTO+0.00%
MEDirect Latino, Inc.
$0.00
EPRSQ-99.00%
EPIRUS Biopharmaceuticals, Inc.
$0.00
XCRP+0.00%
Xcorporeal, Inc.
$0.00
GWHP-90.00%
Global WholeHealth Partners Corporation
$0.00
BLEVF+0.00%
Beleave Inc.
$0.00
ORVRF+0.00%
Orchid Ventures, Inc.
$0.00